PRL effects on breast cancer are mediated by interaction with its receptor (PRLR), a member of the cytokine receptor superfamily, characterized by a tripartite structure: an extracellular ligand-binding domain, a short transmembrane domain, and an intracellular domain. Here, PRL is linked to breast cancer.